Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

AB0124

From Wikipedia, the free encyclopedia

Pharmaceutical compound
AB0124
Clinical data
Other namesAB-0124; ABO124; ABO-124
Drug classSerotonin5-HT2A receptorpositive allosteric modulator
Identifiers
  • N-[2-(dimethylamino)ethyl]-4-(2-phenylethyl)piperidine-2-carboxamide
PubChemCID
Chemical and physical data
FormulaC18H29N3O
Molar mass303.450 g·mol−1
3D model (JSmol)
  • CN(C)CCNC(=O)C1CC(CCN1)CCC2=CC=CC=C2
  • InChI=1S/C18H29N3O/c1-21(2)13-12-20-18(22)17-14-16(10-11-19-17)9-8-15-6-4-3-5-7-15/h3-7,16-17,19H,8-14H2,1-2H3,(H,20,22)
  • Key:YAFSEZSVGMQXTE-UHFFFAOYSA-N

AB0124 is aserotonin5-HT2A receptorpositive allosteric modulator.[1][2][3] It is highlyselective for potentiation of the serotonin 5-HT2A receptor, with no potentiation of the serotonin5-HT2B and5-HT2C receptors.[1][2] In addition, it showed noorthostericagonistic activity at any of the serotonin5-HT2 receptors.[1] AB0124 has been studied in combination with the serotonin 5-HT2 receptor agonist(R)-DOI inanimal models ofcocaine use disorder.[2][1] Thechemical synthesis of AB0124 has been described.[3] The drug waspatented in 2022[3] and was first described in thescientific literature by 2024.[2][1]

See also

[edit]

References

[edit]
  1. ^abcdeMerritt RF, Anastasio N, Zhou J, Cunningham K (January 2026). "ACNP 64th Annual Meeting: Poster Abstracts P292-583".Neuropsychopharmacology.51 (Suppl 1):243–409.doi:10.1038/s41386-025-02280-3.PMC 12783661.PMID 41507445.
  2. ^abcdBolinger AA, Zamora J, Merritt CR, Anastasio NC, Cunningham KA, Zhou J (March 2024).Discovery of novel serotonin 5-HT2A receptor positive allosteric modulators(PDF). 16TH Annual Behavior, Biology, and Chemistry: Translational Research in Substance Use Disorders, San Antonio, Texas | Embassy Landmark | 22-24 March 2024.Synthesizing and screening novel small molecules, we identified potent positive allosteric modulators (PAMs) of 5-HT2AR. Further analysis and comparison against CNS receptors, channels, and transporters led to the identification of AB0124 a potential candidate with high specificity. This compound has demonstrated functional increases in 5-HT-induced Ca2+ release at the micromolar level for the 5-HT2AR over other serotonin receptors. With promising in vitro pharmacological and physicochemical profiles, our novel 5-HT2AR PAMs hold potential as neurotherapeutics for [cocaine use disorder (CUD)].
  3. ^abcWO 2023/023287A1, Zhou J, Cunningham KA, Bolinger AA, Anastasio NC, "Novel heterocyclic compounds as serotonin (5-ht) 5-ht2a and 5-ht2c receptor positive allosteric modulators", issued 23 February 2023, assigned to University of Texas System, University of Texas at Austin 
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=AB0124&oldid=1333756690"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp